Protalix Biotherapeutics Newsroom

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for Pegunigalsidase Alfa

PR NewswireDec 9 06:30 ET

Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 14 11:35 ET · Conference Call

Protalix BioTherapeutics Reports Profit In Q3; Announces Positive Phase 1 Data For PRX-115

RTTNewsNov 14 07:48 ET

Protalix BioTherapeutics Q3 24 Earnings Conference Call At 8:30 AM ET

RTTNewsNov 14 07:34 ET

Protalix Biotherapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 14 07:07 ET · Announcements

Protalix Biotherapeutics | 8-K: Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results

SECNov 14 07:02 ET

Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $18M

MT NewswiresNov 14 06:52 ET

Protalix BioTherapeutics GAAP EPS of $0.03, Revenue of $17.96M

Seeking AlphaNov 14 06:51 ET

Protalix BioTherapeutics 3Q Net $3.24M >PBD.DU

Dow JonesNov 14 06:50 ET

Earnings Scheduled For November 14, 2024

BenzingaNov 14 03:32 ET

Here's the Major Earnings Before the Open Tomorrow

Seeking AlphaNov 13 18:00 ET

Earnings Outlook For Protalix BioTherapeutics

BenzingaNov 13 12:02 ET

Kepler Capital Remains a Buy on PLUXEE N.V. (PLX)

TipRanksNov 9 20:48 ET · Ratings

Earnings Preview: PLX to Report Financial Results Pre-market on November 14

Moomoo NewsNov 8 20:00 ET

Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024

PR NewswireNov 7 06:50 ET

Express News | Protalix BioTherapeutics To Present Data From Phase I Clinical Trial Of PRX-115 Recombinant PEGylated Uricase Product Candidate

BenzingaOct 25 07:19 ET

Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024

PR NewswireOct 25 07:18 ET

Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PR NewswireSep 4 06:50 ET

Express News | Protalix BioTherapeutics Announced That It Has Repaid In Full Its 7.50% Senior Secured Convertible Promissory Notes Financed Entirely With Available Cash

BenzingaSep 3 06:51 ET

Is Protalix BioTherapeutics, Inc. (PLX) The Best Rated Penny Stock To Buy According to Analysts?

Yahoo FinanceAug 30 08:38 ET